Full-length isoform sequencing for resolving the molecular basis of Charcot-Marie-Tooth 2A.
Full-length isoform sequencing for resolving the molecular basis of Charcot-Marie-Tooth 2A.
复制标题
用于解析 Charcot-Marie-Tooth 2A 分子基础的全长异构体测序。
DOI:
10.1101/2023.02.07.526487
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
Stergachis,AndrewB;Blue,ElizabethE;Gillentine,MadelynA;Wang,Lee-Kai;Schwarze,Ulrike;Cortés,AdrianaSedeño;Ranchalis,Jane;Allworth,Aimee;Bland,AustinE;Chanprasert,Sirisak;Chen,Jingheng;Doherty,Daniel;Folta,AndrewB;Glass,Ian;
ObjectivesTranscript sequencing of patient-derived samples has been shown to improve the diagnostic yield for solving cases of suspected Mendelian conditions, yet the added benefit of full-length long-read transcript sequencing is largely unexplored.MethodsWe applied short-read and full-length transcript sequencing and mitochondrial functional studies to a patient-derived fibroblast cell line from an individual with neuropathy that previously lacked a molecular diagnosis.ResultsWe identified an intronic homozygousMFN2c.600-31T>G variant that disrupts the branch point critical for intron 6 splicing. Full-length long-read isoform complementary DNA (cDNA) sequencing after treatment with a nonsense-mediated mRNA decay (NMD) inhibitor revealed that this variant creates 5 distinct altered splicing transcripts. All 5 altered splicing transcripts have disrupted open reading frames and are subject to NMD. Furthermore, a patient-derived fibroblast line demonstrated abnormal lipid droplet formation, consistent with MFN2 dysfunction. Although correctly spliced full-lengthMFN2transcripts are still produced, this branch point variant results in deficient MFN2 levels and autosomal recessive Charcot-Marie-Tooth disease, axonal, type 2A (CMT2A).DiscussionThis case highlights the utility of full-length isoform sequencing for characterizing the molecular mechanism of undiagnosed rare diseases and expands our understanding of the genetic basis for CMT2A.